Search research articles
Contact Us
Filters
Showing results (351-360 of 426) with videos related to
Page
of 43
Sort By:
Cancer Research
|
March 31, 2001
Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591)
A M Ballangrud, W H Yang, D E Charlton, et al.
JCI Insight
|
November 16, 2018
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations
Patrizia Mondello, Elliott J Brea, Elisa De Stanchina, et al.
Cancer Immunology, Immunotherapy : CII
|
June 10, 2010
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
Lee M Krug, Tao Dao, Andrew B Brown, et al.
JCI Insight
|
March 30, 2017
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations
Patrizia Mondello, Elliott J Brea, Elisa De Stanchina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2006
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
Nicole Lamanna, Matt Kalaycio, Peter Maslak, et al.
Blood Advances
|
May 13, 2022
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment
Christopher M Bourne, Sung Soo Mun, Tao Dao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 24, 1999
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia
G Sgouros, A M Ballangrud, J G Jurcic, et al.
Blood
|
January 25, 2023
Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blocker
Megan M Dacek, Keifer G Kurtz, Patrick Wallisch, et al.
Plos One
|
September 20, 2007
PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice
Michael R McDevitt, Debjit Chattopadhyay, Jaspreet S Jaggi, et al.
Journal for Immunotherapy of Cancer
|
January 14, 2026
Trispecific targeting of T cells engineered with TCR mimic antibodies to limit antigen escape
Tao Dao, Guangyan Xiong, Jeremy Meyerberg, et al.
Page
of 43
Search research articles
Search
Showing results (351-360 of 426) with videos related to
Sort By:
Page
of 43
Cancer Research
|
March 31, 2001
Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591)
A M Ballangrud, W H Yang, D E Charlton, et al.
JCI Insight
|
November 16, 2018
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations
Patrizia Mondello, Elliott J Brea, Elisa De Stanchina, et al.
Cancer Immunology, Immunotherapy : CII
|
June 10, 2010
WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
Lee M Krug, Tao Dao, Andrew B Brown, et al.
JCI Insight
|
March 30, 2017
Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations
Patrizia Mondello, Elliott J Brea, Elisa De Stanchina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 8, 2006
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
Nicole Lamanna, Matt Kalaycio, Peter Maslak, et al.
Blood Advances
|
May 13, 2022
Unmasking the suppressed immunopeptidome of EZH2-mutated diffuse large B-cell lymphomas through combination drug treatment
Christopher M Bourne, Sung Soo Mun, Tao Dao, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 24, 1999
Pharmacokinetics and dosimetry of an alpha-particle emitter labeled antibody: 213Bi-HuM195 (anti-CD33) in patients with leukemia
G Sgouros, A M Ballangrud, J G Jurcic, et al.
Blood
|
January 25, 2023
Potentiating antibody-dependent killing of cancers with CAR T cells secreting CD47-SIRPα checkpoint blocker
Megan M Dacek, Keifer G Kurtz, Patrick Wallisch, et al.
Plos One
|
September 20, 2007
PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice
Michael R McDevitt, Debjit Chattopadhyay, Jaspreet S Jaggi, et al.
Journal for Immunotherapy of Cancer
|
January 14, 2026
Trispecific targeting of T cells engineered with TCR mimic antibodies to limit antigen escape
Tao Dao, Guangyan Xiong, Jeremy Meyerberg, et al.
Page
of 43